Pfizer Inc (PFE)

$28.03 +0.10 (0.36%)
Market Cap 158.11B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.07
Forward PE 9.29
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 21,179,347
Avg Vol 37,172,895
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 72%
Beta 0.34
Analysts Sell
Price Target $28.92

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
zustrelaax
zustrelaax Sep. 23 at 6:50 PM
$PFE looking at the number of times it is trying to break that 29 level, have feeling that it will straight be placed at 35 once it break the current level
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Sep. 23 at 6:27 PM
$PFE so Moderna CEO comes out and says they are more than just a COVID vaccine company and stock hits new highs... hmmm, where is Bourla and some much needed market pump? Guess them insiders coming in to buy few Million worth of shares doesn't mean anything either... oh well
1 · Reply
zustrelaax
zustrelaax Sep. 23 at 6:13 PM
$PFE again failed at 28.16
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:53 PM
$ABBV $JNJ $MRK $PFE $SLS Part 6. Employees leaving right before change of control. 2 Employees quit yesterday. ✌️🙏❤️‍🩹
2 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:51 PM
$ABBV $JNJ $MRK $PFE $SLS Part 5. 1. Dr. Stergiou stops defending the stock price-radio silence from the CEO means a deal is already done behind the scenes. 2 Social media goes bearish, with calls for the CEO's removal- this can condition investors to accept a buyout. 3 Wild, unexplained stock price swings-volatility without news could signal manipulation. 4 Buyout offers rumors. 5 Sneaky, high-value options trades-big bets by insiders or well-informed players can be a giveaway. $30 options October. (Massive) 6 Message boards full of "Sell this, buy that" posts-bots and trolls try to shake out retail investors. 7 Odd price action before major milestones-stock drops before big news is a setup for a takeover. 8 Cluster Insider Buys by Independent BOD than nothing because of MNPI. 9. Stock price and sentiment disconnected from reality-if the fundamentals are strong but the price tanks, watch out. 10. Top executives COC Golden Parachutes in June 2026. 😘✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:36 PM
$ABBV $JNJ $MRK $PFE $SLS Part 4. Weak hands that are selling because of overall market weakness I need you all to know that companies get bought and sold through market up’s and down. This is a just minor correction. S&P just hit all time high recently so sit back, Relax and wait for the T1 halt. Traders and Repositioners will be left on the sidelines. Sellas is down to 11 Full time employees now and the structure is very lean before change of control. ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:22 PM
$ABBV $JNJ $MRK $PFE $SLS Part 3. Both Sellas Employees that left yesterday signed a non-disclosure agreement (NDA) signed before a company buyout legally prevents workers from leaking confidential acquisition plans, financial records, or proprietary trade secrets. Plus The Existing employees usually need added value (like a bonus) for the NDA to be binding. Sellas to me has now become an immediate BO play than a data play as every passing day it’s clear to me that data is nothing short of CURATIVE. ✌️🙏❤️‍🩹
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:13 PM
$ABBV $JNJ $MRK $PFE $SLS Part 2. Why Employees Quit Before a Buyout? • Rampant uncertainty: Rumors spark panic about future layoffs and structural shifts. • Loss of culture: The unique environment that made the workplace enjoyable starts to fade. • Awaiting equity risk: Leaving too early means forfeiting unvested stock options or RSUs. • Proactive exits: Top performers prefer securing new jobs on their own terms rather than waiting to be cut. ✌️🙏❤️‍🩹
0 · Reply
zustrelaax
zustrelaax Sep. 23 at 4:23 PM
$PFE trying hard to break that 28.2 , next will be 29.2
0 · Reply
La_Parka3
La_Parka3 Sep. 23 at 4:14 PM
$MRNA $PFE Anti-vaxxers thinking they are going to die after the shot:
1 · Reply
Latest News on PFE
Pfizer CEO Bourla plans to attend White House state dinner for China's Xi, source says

Sep 22, 2026, 10:49 AM EDT - 1 day ago

Pfizer CEO Bourla plans to attend White House state dinner for China's Xi, source says

Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts

Sep 22, 2026, 10:00 AM EDT - 1 day ago

Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts

Pfizer Transcript: U.S. All Stars Conference

Sep 22, 2026, 6:50 AM EDT - 1 day ago

Pfizer Transcript: U.S. All Stars Conference

Pharmaceutical Companies Push Trump Administration to Protect China Deals

Sep 21, 2026, 5:41 PM EDT - 1 day ago

Pharmaceutical Companies Push Trump Administration to Protect China Deals

LLY MRK

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Sep 15, 2026, 10:00 AM EDT - 8 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Sep 14, 2026, 10:45 AM EDT - 9 days ago

Pfizer Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

Sep 13, 2026, 10:39 AM EDT - 10 days ago

Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

Here are the stocks to favor in the fourth quarter — and those you should avoid

Sep 10, 2026, 6:02 PM EDT - 12 days ago

Here are the stocks to favor in the fourth quarter — and those you should avoid

AAPL ABT ADBE AMZN AVGO BAC BMY

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

Sep 2, 2026, 9:00 AM EDT - 21 days ago

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

XRAY

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

Aug 31, 2026, 1:20 PM EDT - 23 days ago

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

LLY NVO TAK

Trump administration to announce drug pricing deals

Aug 31, 2026, 12:09 PM EDT - 23 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK

US FDA approves updated COVID vaccines for 2026-27 season

Aug 27, 2026, 5:48 PM EDT - 26 days ago

US FDA approves updated COVID vaccines for 2026-27 season

MRNA NVAX SNY BNTX

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

Aug 27, 2026, 4:30 PM EDT - 26 days ago

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

BNTX

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

Aug 26, 2026, 12:48 PM EDT - 4 weeks ago

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

AMGN LLY

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 1:45 PM EDT - 5 weeks ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:46 AM EDT - 5 weeks ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Aug 14, 2026, 11:11 AM EDT - 5 weeks ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Aug 14, 2026, 1:00 AM EDT - 5 weeks ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings Call Transcript: Q2 2026

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Earnings release: Q2 2026

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Slides: Q2 2026

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Quarterly report: Q2 2026

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 7 weeks ago

Pfizer Post Loss on Higher Revenue

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:13 AM EDT - 7 weeks ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Aug 4, 2026, 7:12 AM EDT - 7 weeks ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 4, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 7:48 AM EDT - 7 weeks ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 30, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 7 weeks ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:48 PM EDT - 2 months ago

Pfizer's prostate cancer drug combination gets US FDA priority review

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 22, 2026, 4:30 PM EDT - 2 months ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

Jul 21, 2026, 7:10 PM EDT - 2 months ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 16, 2026, 1:39 PM EDT - 2 months ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 10, 2026, 11:23 AM EDT - 2 months ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 2 months ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 2 months ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 2 months ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 3 months ago

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 3 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 3 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 3 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 3 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 3 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 3 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 3 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 3 months ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 3 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 3 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 3 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 3 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 3 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 3 months ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 3 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 3 months ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 3 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 3 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

zustrelaax
zustrelaax Sep. 23 at 6:50 PM
$PFE looking at the number of times it is trying to break that 29 level, have feeling that it will straight be placed at 35 once it break the current level
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Sep. 23 at 6:27 PM
$PFE so Moderna CEO comes out and says they are more than just a COVID vaccine company and stock hits new highs... hmmm, where is Bourla and some much needed market pump? Guess them insiders coming in to buy few Million worth of shares doesn't mean anything either... oh well
1 · Reply
zustrelaax
zustrelaax Sep. 23 at 6:13 PM
$PFE again failed at 28.16
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:53 PM
$ABBV $JNJ $MRK $PFE $SLS Part 6. Employees leaving right before change of control. 2 Employees quit yesterday. ✌️🙏❤️‍🩹
2 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:51 PM
$ABBV $JNJ $MRK $PFE $SLS Part 5. 1. Dr. Stergiou stops defending the stock price-radio silence from the CEO means a deal is already done behind the scenes. 2 Social media goes bearish, with calls for the CEO's removal- this can condition investors to accept a buyout. 3 Wild, unexplained stock price swings-volatility without news could signal manipulation. 4 Buyout offers rumors. 5 Sneaky, high-value options trades-big bets by insiders or well-informed players can be a giveaway. $30 options October. (Massive) 6 Message boards full of "Sell this, buy that" posts-bots and trolls try to shake out retail investors. 7 Odd price action before major milestones-stock drops before big news is a setup for a takeover. 8 Cluster Insider Buys by Independent BOD than nothing because of MNPI. 9. Stock price and sentiment disconnected from reality-if the fundamentals are strong but the price tanks, watch out. 10. Top executives COC Golden Parachutes in June 2026. 😘✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:36 PM
$ABBV $JNJ $MRK $PFE $SLS Part 4. Weak hands that are selling because of overall market weakness I need you all to know that companies get bought and sold through market up’s and down. This is a just minor correction. S&P just hit all time high recently so sit back, Relax and wait for the T1 halt. Traders and Repositioners will be left on the sidelines. Sellas is down to 11 Full time employees now and the structure is very lean before change of control. ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:22 PM
$ABBV $JNJ $MRK $PFE $SLS Part 3. Both Sellas Employees that left yesterday signed a non-disclosure agreement (NDA) signed before a company buyout legally prevents workers from leaking confidential acquisition plans, financial records, or proprietary trade secrets. Plus The Existing employees usually need added value (like a bonus) for the NDA to be binding. Sellas to me has now become an immediate BO play than a data play as every passing day it’s clear to me that data is nothing short of CURATIVE. ✌️🙏❤️‍🩹
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 5:13 PM
$ABBV $JNJ $MRK $PFE $SLS Part 2. Why Employees Quit Before a Buyout? • Rampant uncertainty: Rumors spark panic about future layoffs and structural shifts. • Loss of culture: The unique environment that made the workplace enjoyable starts to fade. • Awaiting equity risk: Leaving too early means forfeiting unvested stock options or RSUs. • Proactive exits: Top performers prefer securing new jobs on their own terms rather than waiting to be cut. ✌️🙏❤️‍🩹
0 · Reply
zustrelaax
zustrelaax Sep. 23 at 4:23 PM
$PFE trying hard to break that 28.2 , next will be 29.2
0 · Reply
La_Parka3
La_Parka3 Sep. 23 at 4:14 PM
$MRNA $PFE Anti-vaxxers thinking they are going to die after the shot:
1 · Reply
ajbski
ajbski Sep. 23 at 3:41 PM
$NVAX “…looking at Pfizer's $PFE pipeline priorities, market competition, and historical partnerships, the most likely targets for use of Matrix-M technology are: 1. Flu / Combination Vaccines 2. Shingles 3. RSV” https://share.google/aimode/xUeYhJNTqtCqnseZu
0 · Reply
zustrelaax
zustrelaax Sep. 23 at 3:31 PM
$PFE news
0 · Reply
brunoq14
brunoq14 Sep. 23 at 3:20 PM
$PFE Is PFE immune to these selloff days? If so, why?
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Sep. 23 at 3:08 PM
$PFE - Whee
0 · Reply
Find_the_Cure
Find_the_Cure Sep. 23 at 2:39 PM
$PFE 🤮☹️
0 · Reply
FlowAnomaly
FlowAnomaly Sep. 23 at 2:28 PM
$MRNA calls mega printing $PFE $GOOGL $PLTR
0 · Reply
Mrjt001
Mrjt001 Sep. 23 at 2:04 PM
$PFE + 90%🔥
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 1:51 PM
$ABBV $JNJ $MRK $PFE $SLS .20 cent spread at open, Repositioners be careful. ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 1:22 PM
$ABBV $JNJ $MRK $PFE $SLS If details of a buyout leak during standard trading hours $SLS stock price might spike instantly. Rather than a company-requested T1 news halt, this rapid price movement typically triggers an automatic T5 volatility halt ! ✌️🙏❤️‍🩹
1 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 23 at 12:37 PM
$ABBV $JNJ $MRK $PFE $SLS Even a blind squirrel 🐿️ right now can see a BO coming here. T1 halt can hit anytime before PR. My money is on $JNJ.✌️🙏❤️‍🩹
0 · Reply
Nasfact
Nasfact Sep. 23 at 12:09 PM
$SLS $JNJ $MRK $PFE $ABBV Speculation but worth it...
1 · Reply
La_Parka3
La_Parka3 Sep. 23 at 9:25 AM
$MRNA $PFE $BNTX $MRK Nieces of uncles who are Moderna shorts, watching their uncles get poorer by the day after every animated, convincing breakfast-table speech about mRNA vaccines causing “turbo cancer.”
0 · Reply